IMMX · Categories · Form 4

IMMX - SEC Form 4 insider transactions

Immix Biopharma Inc. (IMMX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for IMMX

• 5d
  Director Chang Nancy T was granted 6,250 shares, increasing direct ownership by 1% to 428,190 units (SEC Form 4)

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 5d
  SEC Form 4 filed by CFO, President Morris Gabriel S

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 5d
  Director Adams Helen C. was granted 6,250 shares, increasing direct ownership by 4% to 181,004 units (SEC Form 4)

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 5d
  Director Marquet Magda was granted 6,250 shares, increasing direct ownership by 14% to 52,342 units (SEC Form 4)

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 5d
  Director Ng Carey was granted 6,250 shares, increasing direct ownership by 31% to 26,250 units (SEC Form 4)

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 5d
  Director Chudnovsky Yekaterina was granted 6,250 shares (SEC Form 4)

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 5d
  Director Buchan Jane was granted 6,250 shares, increasing direct ownership by 28% to 28,705 units (SEC Form 4)

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 5d
  SEC Form 4 filed by CEO and Chairman Rachman Ilya M

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 5d
  Director Hsu Jason was granted 6,250 shares, increasing direct ownership by 0.70% to 899,250 units (SEC Form 4)

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 174d
  SEC Form 4 filed by Director Chang Nancy T

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 345d
  SEC Form 4 filed by Director Ng Carey

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 345d
  SEC Form 4 filed by CFO Morris Gabriel S

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 345d
  SEC Form 4 filed by Director Marquet Magda

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 345d
  SEC Form 4 filed by Director Adams Helen C.

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 345d
  SEC Form 4 filed by Director Chudnovsky Yekaterina

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 345d
  SEC Form 4 filed by CEO and Chairman Rachman Ilya M

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 345d
  SEC Form 4 filed by Director Hsu Jason

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 345d
  SEC Form 4 filed by Director Buchan Jane

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 712d
  SEC Form 4 filed by Director Adams Helen C.

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 712d
  SEC Form 4 filed by Director Marquet Magda

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 712d
  SEC Form 4 filed by Director Hsu Jason

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 712d
  SEC Form 4 filed by Director Ng Carey

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 712d
  SEC Form 4 filed by CFO Morris Gabriel S

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 712d
  SEC Form 4 filed by Director Buchan Jane

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 712d
  SEC Form 4 filed by Director Chudnovsky Yekaterina

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 712d
  SEC Form 4 filed by CEO and Chairman Rachman Ilya M

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 744d
  Adams Helen C. was granted 161,981 shares, increasing direct ownership by 1,244% to 174,754 units (SEC Form 4)

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 744d
  Buchan Jane was granted 2,459 shares, increasing direct ownership by 12% to 22,455 units (SEC Form 4)

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 744d
  SEC Form 4 filed by Hsu Jason

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 744d
  Rachman Ilya M was granted 218,359 shares, increasing direct ownership by 24% to 1,130,359 units (SEC Form 4)

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 744d
  Morris Gabriel S was granted 242,500 shares, increasing direct ownership by 226% to 280,034 units (SEC Form 4)

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 744d
  SEC Form 4 filed by Ng Carey

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 744d
  Marquet Magda was granted 46,157 shares (SEC Form 4)

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 937d
  SEC Form 4 filed by Morris Gabriel S (Amendment)

  4/A - Immix Biopharma, Inc. (0001873835) (Issuer)
• 937d
  SEC Form 4 filed by Rachman Ilya M (Amendment)

  4/A - Immix Biopharma, Inc. (0001873835) (Issuer)
• 992d
  SEC Form 4: Ng Carey bought $25,760 worth of shares (10,000 units at $2.58)

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 993d
  SEC Form 4: Adams Helen C. bought $38,492 worth of shares (13,000 units at $2.96)

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 995d
  SEC Form 4: Hsu Jason bought $25,317 worth of shares (10,000 units at $2.53), increasing direct ownership by 1% to 685,000 units

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 996d
  SEC Form 4: Buchan Melissa Jane bought $49,226 worth of shares (20,000 units at $2.46)

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 999d
  SEC Form 4: Marquet Magda bought $22,213 worth of shares (9,000 units at $2.47)

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 1001d
  SEC Form 4: Marquet Magda bought $24,722 worth of shares (10,000 units at $2.47)

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 1002d
  SEC Form 4: Marquet Magda bought $2,010 worth of shares (1,000 units at $2.01)

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 1015d
  SEC Form 4 filed by Chudnovsky Yekaterina

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 1024d
  SEC Form 4 filed by Rachman Ilya M

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 1024d
  SEC Form 4 filed by Ng Carey

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 1024d
  SEC Form 4 filed by Morris Gabriel S

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 1024d
  SEC Form 4 filed by Buchan Melissa Jane

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 1024d
  SEC Form 4 filed by Marquet Magda

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 1024d
  SEC Form 4 filed by Adams Helen C.

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 1024d
  SEC Form 4 filed by Hsu Jason

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 1296d
  SEC Form 4: Rachman Ilya M bought $5,225 worth of shares (5,200 units at $1.00), increasing direct ownership by 0.58% to 907,700 units

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 1296d
  SEC Form 4: Morris Gabriel S bought $4,888 worth of shares (5,200 units at $0.94), increasing direct ownership by 7% to 81,316 units

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 1412d
  SEC Form 4: Senn Sean sold $550 worth of shares (200 units at $2.75), decreasing direct ownership by 0.02% to 899,800 units (Amendment)

  4/A - Immix Biopharma, Inc. (0001873835) (Issuer)
• 1416d
  SEC Form 4: Senn Sean sold $550 worth of shares (200 units at $2.75), decreasing direct ownership by 0.02% to 899,800 units

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 1416d
  SEC Form 4 filed by Adams Helen C.

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 1416d
  SEC Form 4 filed by Marquet Magda

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 1416d
  SEC Form 4 filed by Rachman Ilya M

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 1416d
  SEC Form 4 filed by Ng Carey

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 1416d
  SEC Form 4 filed by Buchan Melissa Jane

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)
• 1416d
  SEC Form 4 filed by Hsu Jason

  4 - Immix Biopharma, Inc. (0001873835) (Issuer)

Other IMMX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends